ArticleBMC nephrology2025
Development and validation of a predictive model for upper gastrointestinal bleeding in peritoneal dialysis patients: a retrospective, multicenter cohort study.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe incidence of upper gastrointestinal bleeding (UGIB) in peritoneal dialysis (PD) patients was higher than that in the general population. Although there have been studies on the risk factors of UGIB in PD patients, few studies had established the model of UGIB in PD patients. The purpose of this study was to establish and verify a predictive model of UGIB in PD patients.
methodsThis retrospective study was conducted between February 1, 2007, and November 15, 2021. The patients were divided into training and validation sets in a 1:1 ratio. The least absolute shrinkage and selection operator (LASSO) regression was used to screen potential risk factors for UGIB. These risk factors were used to generate a prognostic nomogram. The nomogram model predictive performance was evaluated by receiver operating characteristic (ROC)curves, calibration curves and decision curve analysis (DCA).
resultsA total of 2107 eligible patients were included in this study. 114 patients suffered from UGIB. After LASSO regression analysis, five representative variables were included in the nomogram: the use of calcium, the use of proton pump inhibitors (PPIs), the history of UGIB, hemoglobin, and uric acid. The C-index of the training set was 0.859 (0.810-0.909), and the C-index of the validation set was 0.874 (0.829-0.919).
conclusionUsing Calcium and PPIs, the history of UGIB, hemoglobin, and uric acid were important predictors of UGIB in PD patients. The nomogram developed and validated in this study has the potential to become an effective tool for clinicians to predict UGIB in PD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.